Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

BACKGROUND: We aimed to clarify the benefits of the addition of rh‐endostatin into concurrent chemoradiotherapy (CCRT) versus CCRT alone for locally advanced non‐small cell lung cancer (NSCLC) by a meta‐analysis. METHODS: PubMed, Embase, Cochrane Central Register of Controlled Trials, Wanfang and Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Zhai, Yirui, Men, Yu, Wang, Jianyang, Deng, Lei, Wang, Wenqing, Bao, Yongxing, Yang, Xu, Sun, Shuang, Ma, Zeliang, Liu, Yunsong, Wang, Jun, Zhu, Hui, Hui, Zhouguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636201/
https://www.ncbi.nlm.nih.gov/pubmed/34676669
http://dx.doi.org/10.1111/1759-7714.14188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636201/
https://www.ncbi.nlm.nih.gov/pubmed/34676669
http://dx.doi.org/10.1111/1759-7714.14188

Ejemplares similares